Altimmune CEO Purchases $70,790 in Stock Amid Weak Q4 Results
Altimmune President and CEO Jerome Benedict Durso acquired 20,000 shares of the company on March 6, 2026, paying a weighted average of $3.5395 per share for a total of $70,790. The purchase occurred while the stock traded near $3.54 after a 15% decline over the prior week. The company recently reported fourth-quarter 2025 results that missed expect…